This research trial studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The information generated will help doctors better understand treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes for patients, as well as guide future research for using Y90 therapy, especially for those conditions where data is currently very limited or lacking.
Principal Investigator: Marc Matrana, MD
|Full Protocol Title||Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Registry|
Main Campus - Jefferson Highway
|Sponsor||Vanderbilt-Ingram Cancer Center|
|Change in Care||Participating will NOT change your care|